Life Sciences

English courts will thrive in life sciences patent litigation alongside the UPC

Rather than being overshadowed by the new pan-EU system, the UK will remain a crucial venue for pharma and biotech disputes

English courts will thrive in life sciences patent litigation alongside the UPC
Genentech’s troubles highlight biosimilar trade secret risks
23 Jul 2021

Genentech’s troubles highlight biosimilar trade secret risks

Two founders of JHL Biotech have recently been indicted for conspiracy to steal trade secrets from the Californian company, while two other individuals pleaded guilty to similar charges

Australian pharma patentees must remain vigilant on third-party damages
22 Jul 2021

Australian pharma patentees must remain vigilant on third-party damages

Recent decisions have calmed concerns about a surge of lawsuits against patentees by third parties, but a significant risk remains

Latest

View all
20 Jul 2021

Biopharma M&A has fallen off a cliff – but IP owners in the sector have reasons to be cheerful

The number and value of acquisitions have both tumbled further than in the early months of 2020 Read more

16 Jul 2021

Biden’s march-in rights reversal is further evidence of US policy shift on pharma IP rights

US president abandons Trump-era proposal to rule out patent suspensions under the Bayh-Dole Act Read more

15 Jul 2021

China’s patent linkage system is finally up and running

What the final implementing measures of the Hatch-Waxman-style framework mean for biopharma patentees and generics Read more

14 Jul 2021

Arthrex could offer life sciences patents extra layer of protection

Co-published - An additional level of scrutiny for IPR decisions will be a boon for owners of valuable pharma and biotech patents Read more

News

View all
26 Jun 2021

For India and other countries, an IP waiver is a distraction not a solution to the covid-19 vaccine crisis

A TRIPs suspension will not provide the shot in the arm that millions of Indians need, but the country does have a major role to play in supplying vaccines to the world Read more

8 May 2021

Biden’s backing for the covid vaccine IP waiver should concern all rights owners

This week’s unprecedented move raises a series of worrying questions and puts in doubt the administration’s commitment to fostering innovative activity Read more

26 Apr 2021

Get smarter about covid patents or pay the price

On World IP Day it's time to get a few things straight about where the real problems in getting jabs to those who need them really lie Read more

15 Feb 2021

Uptrend in oppositions could spell costly delays for Indian patent applicants

Practitioners say greater attention to detail during the prosecution process can head off frivolous challenges Read more

Analysis

View all
8 Jul 2021

New SPC data demonstrates the commercial power of patent extension rights in Europe

A recent report into supplementary protection certificates provides crucial insights for IP strategists and policy-makers Read more

1 Jul 2021

Everything you need to know about SCOTUS’ Minerva ruling on assignor estoppel

In a 5-4 decision the court’s justices significantly narrowed the scope of the doctrine that prevents assignors from challenging patents in court. Read more

29 Jun 2021

University and Big Pharma JV’s $145 million take-off is a big boost for tech transfer dealmaking

Apollo Therapeutics is an innovative biotech formed by three UK universities and three major companies, with a promising model for creating and monetising life sciences IP Read more

29 Jun 2021

Patenting activity in India remains strong despite pandemic

Indian Patent Office also largely maintained its efficiency gains during 2020, after years of investment in examination capacity Read more

Insights

View all
12 Aug 2020

IP market news highlights

A rundown of some of the top news stories on the IAM platform in May, June and July Read more

12 Aug 2020

As the fallout from covid continues, the two IP superpowers offer different messages

While China cheers an uptick in applications, the USPTO warns of a prolonged downturn Read more

8 Jun 2020

IP Market news highlights

IAM’s biggest spring reads Read more

8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more